https://www.discoveriesnews.com/ema-europe-approvals/ema-recommends-new-immunotherapy-for-relapsed-small-cell-lung-cancer2026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/eu-backs-new-treatment-for-rare-neurological-disease-niemann-pick-type-c2026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/ema-briefing-omicron-ba4-ba5-predominant-in-july2026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/ema-adopts-first-list-of-critical-medicines-for-covid-192026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/ema-guidance-supports-development-of-new-antibiotics2026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/first-therapy-to-treat-two-types-of-niemann-pick-disease2026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/first-therapy-for-the-rare-genetic-disorder-aadc-deficiency2026-05-03T22:23:29+00:000.8https://www.discoveriesnews.com/ema-europe-approvals/covid-19-vaccines-and-their-reported-side-effects2026-05-03T22:23:29+00:000.8